Risk screening and interventional management of cardiometabolic diseases related to visceral adiposity
LIU Jing
KONG Xiang-qing
Abstract：Visceral adipose tissue has emerged as a critical factor in cardiometabolic diseases,yet its role remains underrecognized in current prevention and management system.Conventional approaches often regard blood pressure,glucose,and lipid levels as the core factors,neglecting abnormal fat distribution as an upstream risk factor.The main barrier to visceral adipose tissue management is not the lack of diagnostic tools but insufficient awareness of risk recognition and proactive evaluation.Strengthening physician education and training,promoting the use of visceral adiposity indices and imaging-based perirenal fat assessment,and advancing development of novel diagnosis,medicines and devices targeting visceral adipose tissue may enhance early detection and prevention of cardiometabolic diseases.The patients with abdominal obesity,normal-weight obesity,or metabolic abnormalities without typical conventional indicators should undergo routine visceral adipose tissue-related risk evaluation and management.
Keywords：visceral adipose tissuemetabolic diseaserisk screeningintervention
Publication Date：2025-11-01
Online Publishing Date：2025-12-10(First online date of this platform, not the publication date of the document)
Pages：3( 910-912 )